Peringkat dalam Saham
#37811
Idogen AB (publ) is a Swedish biotechnology company specializing in the... Idogen AB (publ) is a Swedish biotechnology company specializing in the development of tolerogenic cell therapies. These innovative treatments are engineered to prevent a patient's immune system from attacking crucial elements, including biological agents, transplanted organs, and the body's own cells or tissues. The company's most advanced product in development is IDO 8, designed for individuals with severe haemophilia A who have developed neutralizing antibodies against their vital coagulation factor VIII treatment. Idogen is also developing IDO T, a tolerogenic cell therapy intended to prevent organ transplant rejection, primarily for kidney transplants, and IDO AID, aimed at treating autoimmune diseases. Established in 2008, the company is headquartered in Lund, Sweden.
Harga Saham
$0.01345907
Terakhir disinkronkan: 2024-07-12
Kapitalisasi Pasar
$1.43M
Perubahan (1 hari)
22.16%
Perubahan (1 tahun)
0.00%
Perdagangan Idogen AB (publ) (IDOGEN)
Harga IDOGEN dengan kapitalisasi pasar B
Kapitalisasi pasar dari Idogen AB (publ)(IDOGEN)
Kapitalisasi Pasar: $1.43M
Per August 2026, Idogen AB (publ) memiliki kapitalisasi pasar sebesar $1.43M. Ini menjadikan Idogen AB (publ) sebagai perusahaan 37811th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Idogen AB (publ) dari 2015 hingga 2026
IDOGEN dibandingkan dengan 5 teratas stocks paling populer
| Harga IDOGEN |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+381,741,842.27%
|
|
|
|
|
$4.490T
|
+314,392,894.12%
|
|
|
|
|
$4.162T
|
+291,453,291.30%
|
|
|
|
|
$3.676T
|
+257,418,856.56%
|
|
|
|
|
$2.833T
|
+198,370,668.95%
|
